Zheng Quan Zhi Xing·2025-08-22 16:16Core Viewpoint - The company intends to utilize part of its idle raised funds (including oversubscribed funds) and self-owned funds for cash management to enhance fund efficiency and shareholder returns while ensuring that it does not affect normal operations and investment project construction [1][5]. Fundraising Basic Situation - The company raised a total of RMB 1,216,511,427.60 from the issuance of 21,508,335 shares at a price of RMB 56.56 per share, with a net amount of RMB 1,110,744,306.58 after deducting issuance costs [1]. - The funds were deposited into a special account approved by the board of directors, and a tripartite supervision agreement was signed with the sponsor and the commercial bank [1]. Investment Project Situation - The net amount of raised funds is RMB 111,074.43 million, with a total investment of RMB 99,718.47 million planned for a project to produce 190 tons of high-end pharmaceutical products [2]. - The company has used RMB 18,000 million of the oversubscribed funds for permanent working capital [2]. Cash Management Basic Situation - The company plans to use up to RMB 9 billion of idle raised funds and up to RMB 7 billion of self-owned funds for cash management, with a validity period of 12 months from the date of shareholder approval [3]. - The cash management aims to improve fund efficiency and ensure the safety and liquidity of investments [3][4]. Investment Products - The company will invest in low-risk, high-liquidity financial products, including structured deposits, agreement deposits, and large-denomination certificates of deposit, avoiding high-risk investments [4]. - The investment products will not be pledged, and any special settlement accounts will not hold non-raised funds [4]. Internal Decision-Making Procedures - The board of directors and the supervisory board have approved the cash management proposal, which will be submitted to the shareholders' meeting for final approval [6][7][8]. - The supervisory board believes that the cash management will not affect the normal operations or the intended use of raised funds, thus protecting shareholder interests [9]. Sponsor's Review Opinion - The sponsor has confirmed that the cash management proposal has undergone necessary approval procedures and complies with relevant laws and regulations, ensuring it does not change the intended use of raised funds [10].